Landscape Capital Management, L.L.C. Biogen Inc. Transaction History

Landscape Capital Management, L.L.C.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$220.06 - $304.07 $662,600 - $915,554	-3,011 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $654,711 - $734,322	3,011 New	3,011 $701,000
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $267,081 - $338,287	-959 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $431,459 - $564,230	-1,470 Reduced 60.52%	959 $339,000
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $625,516 - $745,484	2,429 New	2,429 $705,000
Q4 2017 Feb 13, 2018	SELL	$307.64 - $344.58 $472,227 - $528,930	-1,535 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $431,565 - $506,074	1,535	1,535 $481,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.